Neurocrine Biosciences, Inc. (NBIX) Targets Brain DisordersNeurocrine Biosciences, Inc.NASDAQ:NBIXtraderspro_chartsNeurocrine Biosciences, Inc. (NBIX) develops treatments for neurological and endocrine disorders, focusing on conditions like movement disorders, epilepsy, and hormone-related diseases. The company grows through strong drug adoption, expanding indications, and a deep pipeline targeting high-need conditions. Its focus on specialized therapies supports steady long-term growth in the biotech space. On the chart, NBIX printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.